Mustang Bio, Inc.

US$0.39As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MBIOHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (66.74%)
Div yield —
ROE (43.15%)
Biotechnology
Beta (5Y) 2.20
PE TTM —
TSR TTM (72.79%)
Mkt cap US$2.990M
ROIC (30.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.485
23.02%
129.29%
Hold 0|1|1|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
23.07%
19.74%
23.36%
38.16%
Revenue$M
0.302
0.298
0.309
0.304
0.35%
0.24%
2.47%
3.72%
Peers (US$2.990M)
Cap (US$)
PE
3.015M
—
2.990M
2.491x
Capital
TTM
5Y
10Y
Leveragex
3.070
0.441
0.410
EBIT/Intx
16.45
0.304
0.219
Own earn%
(69.82)
139.17
146.06
Sh yield%
21.32
28.04
28.30
Owners
Insiders/Inst%
2.34
29.16
Short interest%
1.57
SBC / revenue%
3.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
2–7
$1 testx
—
Incr. ROIC%
9